High-dose acetaminophen does not acutely compromise blood-brain barrier permeability in mice.

IF 3.5 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM
Sumaih Zoubi, Dhavalkumar Patel, Yeseul Ahn, Ehsan Nozohouri, Heba Ewida, Ulrich Bickel
{"title":"High-dose acetaminophen does not acutely compromise blood-brain barrier permeability in mice.","authors":"Sumaih Zoubi, Dhavalkumar Patel, Yeseul Ahn, Ehsan Nozohouri, Heba Ewida, Ulrich Bickel","doi":"10.1007/s11011-025-01696-6","DOIUrl":null,"url":null,"abstract":"<p><p>Acetaminophen is widely recognized for its safety as a pain reliever and fever reducer at recommended doses. However, in addition to the well-known hepatotoxic and nephrotoxic effects at overdoses recent animal studies in rats have raised the possibility that acetaminophen at a high dose of 500 mg/kg may lead to acute impairment of the blood-brain barrier (BBB). Because species differences in hepatic and renal toxicity of acetaminophen are present, we assessed here the effect of moderate and severe overdoses of acetaminophen (300 mg/kg and 600 mg/kg, respectively) after intraperitoneal administration in mice on BBB permeability. Using stable isotope-labeled [<sup>13</sup>C<sub>12</sub>]sucrose as a small molecule hydrophilic marker the brain uptake clearance K<sub>in</sub> was measured. Our results showed no significant differences in BBB permeability between vehicle control and acetaminophen treated groups (K<sub>in</sub> of the control group = 0.070 ± 0.025 µL min<sup>-1</sup> g<sup>-1</sup>, K<sub>in</sub> of the 300 mg/kg group = 0.059 ± 0.017 µL min<sup>-1</sup> g<sup>-1</sup>, and K<sub>in</sub> of the 600 mg/kg group = 0.066 ± 0.010 µL min<sup>-1</sup> g<sup>-1</sup>, all values mean ± SD, n = 6) suggesting that even high doses of acetaminophen do not acutely compromise BBB permeability in mice. We did also not observe significant changes in tight junction proteins in brain. These findings support the notion that acetaminophen effects on the BBB may be species-specific among rodents.</p>","PeriodicalId":18685,"journal":{"name":"Metabolic brain disease","volume":"40 7","pages":"258"},"PeriodicalIF":3.5000,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Metabolic brain disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11011-025-01696-6","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Acetaminophen is widely recognized for its safety as a pain reliever and fever reducer at recommended doses. However, in addition to the well-known hepatotoxic and nephrotoxic effects at overdoses recent animal studies in rats have raised the possibility that acetaminophen at a high dose of 500 mg/kg may lead to acute impairment of the blood-brain barrier (BBB). Because species differences in hepatic and renal toxicity of acetaminophen are present, we assessed here the effect of moderate and severe overdoses of acetaminophen (300 mg/kg and 600 mg/kg, respectively) after intraperitoneal administration in mice on BBB permeability. Using stable isotope-labeled [13C12]sucrose as a small molecule hydrophilic marker the brain uptake clearance Kin was measured. Our results showed no significant differences in BBB permeability between vehicle control and acetaminophen treated groups (Kin of the control group = 0.070 ± 0.025 µL min-1 g-1, Kin of the 300 mg/kg group = 0.059 ± 0.017 µL min-1 g-1, and Kin of the 600 mg/kg group = 0.066 ± 0.010 µL min-1 g-1, all values mean ± SD, n = 6) suggesting that even high doses of acetaminophen do not acutely compromise BBB permeability in mice. We did also not observe significant changes in tight junction proteins in brain. These findings support the notion that acetaminophen effects on the BBB may be species-specific among rodents.

大剂量对乙酰氨基酚不会严重损害小鼠血脑屏障的通透性。
在推荐剂量下,对乙酰氨基酚被广泛认为是一种安全的止痛药和退烧药。然而,除了过量服用众所周知的肝毒性和肾毒性作用外,最近在大鼠中进行的动物研究提出了500mg /kg高剂量对乙酰氨基酚可能导致血脑屏障(BBB)急性损伤的可能性。由于对乙酰氨基酚的肝脏和肾脏毒性存在物种差异,因此我们在此评估了小鼠腹腔内给药后中度和重度过量(分别为300 mg/kg和600 mg/kg)对血脑屏障通透性的影响。用稳定同位素标记的[13C12]蔗糖作为小分子亲水性标记物,测定脑摄取清除率Kin。本研究结果显示,对乙酰氨基酚处理组与对照组血脑屏障通透性无显著差异(对照组Kin = 0.070±0.025µL min-1 g-1, 300 mg/kg组Kin = 0.059±0.017µL min-1 g-1, 600 mg/kg组Kin = 0.066±0.010µL min-1 g-1,所有数值均为±SD, n = 6),提示即使高剂量对乙酰氨基酚也不会严重损害小鼠血脑屏障通透性。我们也未观察到脑组织紧密连接蛋白的显著变化。这些发现支持了对乙酰氨基酚对血脑屏障的影响可能在啮齿类动物中具有物种特异性的观点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Metabolic brain disease
Metabolic brain disease 医学-内分泌学与代谢
CiteScore
5.90
自引率
5.60%
发文量
248
审稿时长
6-12 weeks
期刊介绍: Metabolic Brain Disease serves as a forum for the publication of outstanding basic and clinical papers on all metabolic brain disease, including both human and animal studies. The journal publishes papers on the fundamental pathogenesis of these disorders and on related experimental and clinical techniques and methodologies. Metabolic Brain Disease is directed to physicians, neuroscientists, internists, psychiatrists, neurologists, pathologists, and others involved in the research and treatment of a broad range of metabolic brain disorders.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信